IBDEI0H5 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8328,0)
 ;;=377.00^^58^608^99
 ;;^UTILITY(U,$J,358.3,8328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8328,1,3,0)
 ;;=3^Papilledema,Unspec
 ;;^UTILITY(U,$J,358.3,8328,1,4,0)
 ;;=4^377.00
 ;;^UTILITY(U,$J,358.3,8328,2)
 ;;=^89575
 ;;^UTILITY(U,$J,358.3,8329,0)
 ;;=377.02^^58^608^98
 ;;^UTILITY(U,$J,358.3,8329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8329,1,3,0)
 ;;=3^Papilledema,Decreased Ocul Pressure
 ;;^UTILITY(U,$J,358.3,8329,1,4,0)
 ;;=4^377.02
 ;;^UTILITY(U,$J,358.3,8329,2)
 ;;=^269213
 ;;^UTILITY(U,$J,358.3,8330,0)
 ;;=377.03^^58^608^97
 ;;^UTILITY(U,$J,358.3,8330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8330,1,3,0)
 ;;=3^Papilledema w/ Retina D/O
 ;;^UTILITY(U,$J,358.3,8330,1,4,0)
 ;;=4^377.03
 ;;^UTILITY(U,$J,358.3,8330,2)
 ;;=^269214
 ;;^UTILITY(U,$J,358.3,8331,0)
 ;;=377.04^^58^608^40
 ;;^UTILITY(U,$J,358.3,8331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8331,1,3,0)
 ;;=3^Foster-Kennedy Syndrome
 ;;^UTILITY(U,$J,358.3,8331,1,4,0)
 ;;=4^377.04
 ;;^UTILITY(U,$J,358.3,8331,2)
 ;;=^265146
 ;;^UTILITY(U,$J,358.3,8332,0)
 ;;=377.11^^58^608^83
 ;;^UTILITY(U,$J,358.3,8332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8332,1,3,0)
 ;;=3^Optic Atrophy,Primary
 ;;^UTILITY(U,$J,358.3,8332,1,4,0)
 ;;=4^377.11
 ;;^UTILITY(U,$J,358.3,8332,2)
 ;;=^269215
 ;;^UTILITY(U,$J,358.3,8333,0)
 ;;=377.12^^58^608^82
 ;;^UTILITY(U,$J,358.3,8333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8333,1,3,0)
 ;;=3^Optic Atrophy,Postinflammatory
 ;;^UTILITY(U,$J,358.3,8333,1,4,0)
 ;;=4^377.12
 ;;^UTILITY(U,$J,358.3,8333,2)
 ;;=^269216
 ;;^UTILITY(U,$J,358.3,8334,0)
 ;;=377.15^^58^608^81
 ;;^UTILITY(U,$J,358.3,8334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8334,1,3,0)
 ;;=3^Optic Atrophy,Partial
 ;;^UTILITY(U,$J,358.3,8334,1,4,0)
 ;;=4^377.15
 ;;^UTILITY(U,$J,358.3,8334,2)
 ;;=^269219
 ;;^UTILITY(U,$J,358.3,8335,0)
 ;;=377.16^^58^608^80
 ;;^UTILITY(U,$J,358.3,8335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8335,1,3,0)
 ;;=3^Optic Atrophy,Leber's
 ;;^UTILITY(U,$J,358.3,8335,1,4,0)
 ;;=4^377.16
 ;;^UTILITY(U,$J,358.3,8335,2)
 ;;=^85931
 ;;^UTILITY(U,$J,358.3,8336,0)
 ;;=377.31^^58^608^94
 ;;^UTILITY(U,$J,358.3,8336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8336,1,3,0)
 ;;=3^Optic Papillitis
 ;;^UTILITY(U,$J,358.3,8336,1,4,0)
 ;;=4^377.31
 ;;^UTILITY(U,$J,358.3,8336,2)
 ;;=^276874
 ;;^UTILITY(U,$J,358.3,8337,0)
 ;;=377.32^^58^608^89
 ;;^UTILITY(U,$J,358.3,8337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8337,1,3,0)
 ;;=3^Optic Neuritis,Retrobulbar,Acute
 ;;^UTILITY(U,$J,358.3,8337,1,4,0)
 ;;=4^377.32
 ;;^UTILITY(U,$J,358.3,8337,2)
 ;;=^269225
 ;;^UTILITY(U,$J,358.3,8338,0)
 ;;=377.33^^58^608^92
 ;;^UTILITY(U,$J,358.3,8338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8338,1,3,0)
 ;;=3^Optic Neuropathy,Nutritional
 ;;^UTILITY(U,$J,358.3,8338,1,4,0)
 ;;=4^377.33
 ;;^UTILITY(U,$J,358.3,8338,2)
 ;;=^269226
 ;;^UTILITY(U,$J,358.3,8339,0)
 ;;=377.39^^58^608^93
 ;;^UTILITY(U,$J,358.3,8339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8339,1,3,0)
 ;;=3^Optic Neuropathy,Other
 ;;^UTILITY(U,$J,358.3,8339,1,4,0)
 ;;=4^377.39
 ;;^UTILITY(U,$J,358.3,8339,2)
 ;;=^87748
 ;;^UTILITY(U,$J,358.3,8340,0)
 ;;=377.42^^58^608^87
 ;;^UTILITY(U,$J,358.3,8340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8340,1,3,0)
 ;;=3^Optic Nerve Sheaths Hemorrhage
 ;;^UTILITY(U,$J,358.3,8340,1,4,0)
 ;;=4^377.42
 ;;^UTILITY(U,$J,358.3,8340,2)
 ;;=^269233
 ;;^UTILITY(U,$J,358.3,8341,0)
 ;;=377.49^^58^608^86
 ;;^UTILITY(U,$J,358.3,8341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8341,1,3,0)
 ;;=3^Optic Nerve Compression
 ;;^UTILITY(U,$J,358.3,8341,1,4,0)
 ;;=4^377.49
